Sanyal Biotechnology made its exceptionally successful international launch at the EASL International Liver Congress™ 2016 (ILC) for the 51st annual meeting of the European Association for the Study of the Liver on the 13-17 April 2016 at the Fira Barcelona Gran Via, Barcelona, Spain.
April 16, 2016 - Richmond, Virginia and Barcelona, Spain: Sanyal Biotechnology LLC and One Way Liver S.L. (OWL Metabolomics) have initiated a strategic partnership to provide increased value and additional R&D services to basic research and the pharmaceutical industry, announced at the International Liver Congress in Barcelona, Spain. Research companies and institutions who utilize Sanyal [...]
SanyalBio to present at the Virginia Venture Summit at the Creative Office Environments Ashland on April 7th.
SanyalBio have been selected as a market disruptor with growth potential to present at the Virginia Venture Summit annual event, a day-long annual conference for entrepreneurs, capital providers, and ecosystem centers of influence. Local leaders are invited to join leading VCs, investment bankers and angel investors as well as leaders of some of the most [...]
Meet SanyalBio at Southwest Virginia Life Science Forum 2016 at Virginia Tech Carilion Research Institute.
SanyalBio will be presenting at the Southwest Virginia Life Science Forum 2016. The Virginia Biotechnology Association, formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. More than 200 member organizations have joined forces to make Virginia Bio an effective advocate for the biopharmaceutical and [...]
The International Committee for Insulin Resistance (ICIR) is a group of Physicians who are committed to the understanding of the Insulin Resistance Syndrome (IRS) and its associated and its clinical manifestations. The committee serves as a scientific organizing committee of the World Congress of IRS. The goals of the committee are, to further the understanding [...]
This blog, written by Rosana Kapeller, CSO of Nimbus Therapeutics, is part of the “From the Trenches” feature of LifeSciVC. Early this week, Intercept Pharmaceuticals announced the much awaited design of their Ph. 3 clinical trial of Obeticholic Acid (OCA) in NASH (non-alcoholic steatohepatitis) with liver fibrosis (here). The trial, named REGENERATE, will be the [...]
By Katie Demeria on November 30, 2015 With a $3 million capital raise underway, a group of VCU alumni and Health Diagnostic Laboratory veterans have launched a startup to find cures for “the worst epidemic you’ve never heard of.” That’s how Rebecca Caffrey describes the two increasingly prevalent liver diseases that her new company, the [...]
By Kira Peikoff On 1/30/16 AT 9:50 AM Sandra C., a special education teacher in New Jersey, didn’t worry too much when her doctor told her to call a liver specialist. Sure, she got fatigued running around with the schoolchildren, and friends sometimes told her she looked green, but in general she felt healthy—she couldn’t [...]
Rebecca Caffrey March 10, 2015 Sanyal Biotechnology will be attending the 2016 International Liver Conference meeting in Barcelona, Spain, from April 13-17. Please stop by our booth on the trade show floor, or contact us in advance to set up a private meeting to discuss your needs.